Rangeley Capital’s HilleVax HLVX Stock Holding History
Bought
Maintained
Sold
Rangeley Capital's HLVX Position: Q3 2025 in Review
Rangeley Capital sold out of HilleVax (HLVX) in Q3 2025, closing a stake of 153,790 shares — an estimated $306K sold.
Rangeley Capital first reported a position in HLVX in Q2 2025 and held it in 1 quarter. The position peaked at $306K in Q2 2025. 1 fund tracked by Wall St. Rank holds HLVX as of Q3 2025.
- Rangeley Capital reported no remaining HilleVax position as of Q3 2025 after selling out during the quarter.
- Rangeley Capital sold 153,790 HilleVax shares in Q3 2025, an estimated $306K.
- Rangeley Capital first reported a position in HilleVax in Q2 2025 and held it in 1 quarter.
- Rangeley Capital's HilleVax position peaked at $306K in Q2 2025.
- 1 fund tracked by Wall St. Rank held HilleVax as of Q3 2025.
Based on Rangeley Capital's 13F filing for Q3 2025, filed 14 Nov 2025.